Analysts' Actions -- Dr. Pepper, Expedia, GoPro, Nutanix and More

RATINGS CHANGES

Broadcom (AVGO) was upgraded to buy at TheStreet Ratings. You can view the full analysis from the report here: AVGO.

Caleres (CAL) was upgraded to overweight from equal-weight at Morgan Stanley. $37 price target. The company has multiple drivers and the Allen Edmonds deal should add to earnings, Morgan said. 

Dr. Pepper Snapple (DPS) was upgraded to buy at Jefferies. $115 price target. Bai can help drive organic sale growth, Jefferies said. 

Expedia (EXPE) was upgraded to neutral from sell at Citigroup. $130 price target. Hotel business should drive growth in the coming quarters, Citi said. 

Greif (GEF) was upgraded to neutral from underperform at DA Davidson. $54 price target. Operations are improving and the international risk footprint is diminishing, Davidson said. 

GoPro (GPRO) was initiated with a sell rating at Citigroup. $8 price target. Drone market is becoming more saturated and breakeven remains at least two years out, Citi said. 

Nutanix (NTNX) was downgraded to underweight at Morgan Stanley. $20 price target. The company is facing higher memory prices and struggling to execute, Morgan said. 

Southern (SO) was upgraded to buy at Jefferies. $56 price target. The stock has been overly punished for Kemper and Vogtle projects, Jefferies said. 

Southwestern (SWN) was upgraded to hold at Jefferies. $8 price target. The valuation is more attractive, as the stock is down 30% year-to-date, Jefferies said. 

This article was written by a staff member of TheStreet.

More from Stocks

FedEx Tanks After It Fails to Deliver on Earnings

FedEx Tanks After It Fails to Deliver on Earnings

FedEx's Free Cash Flow Offers a Positive Signal for a Sagging Stock

FedEx's Free Cash Flow Offers a Positive Signal for a Sagging Stock

Dow, Stocks Shrug Off Trade War Escalation, End Higher

Dow, Stocks Shrug Off Trade War Escalation, End Higher

Chart of the Day: How Tariff Talk Hurts FedEx Stock

Chart of the Day: How Tariff Talk Hurts FedEx Stock

Experts Are High on Cannabis Stocks' 2019 Prospects

Experts Are High on Cannabis Stocks' 2019 Prospects